224 related articles for article (PubMed ID: 1272073)
1. Nucleation and growth of brushite and calcium oxalate in urine of stone-formers.
Pak CY; Holt K
Metabolism; 1976 Jun; 25(6):665-73. PubMed ID: 1272073
[TBL] [Abstract][Full Text] [Related]
2. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation.
Nicar MJ; Hill K; Pak CY
Metabolism; 1983 Sep; 32(9):906-10. PubMed ID: 6888271
[TBL] [Abstract][Full Text] [Related]
3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
4. Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.
Baumann JM; Lauber K; Lustenberger FX; Wacker M; Zingg EJ
Urol Res; 1985; 13(4):169-74. PubMed ID: 4049602
[TBL] [Abstract][Full Text] [Related]
5. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
[TBL] [Abstract][Full Text] [Related]
6. Study of inhibitor and nucleator activities in calcium stone formers.
Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods.
Pak CY; Hayashi Y; Finlayson B; Chu S
J Lab Clin Med; 1977 Apr; 89(4):891-901. PubMed ID: 845489
[TBL] [Abstract][Full Text] [Related]
8. Urinary supersaturation with respect to brushite in patients suffering calcium oxalate lithiasis.
Berland Y; Boistelle R; Olmer M
Nephrol Dial Transplant; 1990; 5(3):179-84. PubMed ID: 2113644
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
10. Risk Profile of Patients with Brushite Stone Disease and the Impact of Diet.
Siener R; Pitzer MS; Speller J; Hesse A
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764875
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
Woelfel A; Kaplan RA; Pak CY
Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
[TBL] [Abstract][Full Text] [Related]
12. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis.
Fetner CD; Barilla DE; Townsend J; Pak CY
J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659
[TBL] [Abstract][Full Text] [Related]
13. Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.
Pak CY
Invest Urol; 1979 Sep; 17(2):146-8. PubMed ID: 468514
[TBL] [Abstract][Full Text] [Related]
14. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR; Parks JH; Coe FL
Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
[TBL] [Abstract][Full Text] [Related]
15. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.
Pak CY; Galosy RA
Am J Med; 1980 Nov; 69(5):681-9. PubMed ID: 7435510
[TBL] [Abstract][Full Text] [Related]
16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
17. Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients.
Crassweller PO; Oreopoulos DG; Toguri A; Husdan H; Wilson DR; Rapoport A
J Urol; 1978 Jul; 120(1):6-10. PubMed ID: 671607
[TBL] [Abstract][Full Text] [Related]
18. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of primary hyperparathyroidism with and without kidney stones.
Odvina CV; Sakhaee K; Heller HJ; Peterson RD; Poindexter JR; Padalino PK; Pak CY
Urol Res; 2007 Jun; 35(3):123-8. PubMed ID: 17476495
[TBL] [Abstract][Full Text] [Related]
20. Urine risk factors in children with calcium kidney stones and their siblings.
Bergsland KJ; Coe FL; White MD; Erhard MJ; DeFoor WR; Mahan JD; Schwaderer AL; Asplin JR
Kidney Int; 2012 Jun; 81(11):1140-8. PubMed ID: 22358148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
